Table: begin end state 1 17 cytoplasmic 18 37 transmembrane 38 42 non-cytoplasmic 43 62 transmembrane 63 71 cytoplasmic 72 89 transmembrane 90 100 non-cytoplasmic 101 119 transmembrane 120 125 cytoplasmic 126 145 transmembrane 146 175 non-cytoplasmic 176 198 transmembrane 199 219 cytoplasmic 220 240 transmembrane 241 270 non-cytoplasmic 271 292 transmembrane 293 295 cytoplasmic 296 316 transmembrane 317 340 non-cytoplasmic 341 358 transmembrane 359 362 cytoplasmic 363 385 transmembrane 386 393 non-cytoplasmic 394 427 transmembrane 428 447 cytoplasmic 448 480 transmembrane 481 485 non-cytoplasmic 486 504 transmembrane 505 509 cytoplasmic 510 556 transmembrane 557 565 non-cytoplasmic 566 586 transmembrane 587 596 cytoplasmic 597 623 transmembrane 624 632 non-cytoplasmic 633 661 transmembrane 662 677 cytoplasmic
Input: >7023222 FitnessBrowser__ANA3:7023222 MSDSEQGLGAKTSDWPKALFYTALVFSIFQIITAAFHPVSTQVLRATHVGFLLLIVFLSY PAVGKSRPWQPLGWVLGLAGMATAAYQWFFEADLIQRSGELTDADMVIGVVLIVLVFEAA RRVMGWALPIICCIFLAYGLFGQYLPGDLMHRGYGVDQIINQLSFGTEGLYGTPTYVSAT YIFLFILFGAFLEQAGMIRLFTDFAMGLFGHKLGGPAKVAVVSSAMMGTITGSGVANVVT TGQFTIPLMKRFGYRPAFAGGVEATSSMGSQIMPPIMGAVAFIMAETINVPFIEIAKAAL IPALLYFSSVFWMVHLEAKRANLCGLPKDQCPDPWAAVKERWYLLIPLFILIYLLFSGRT PLFSGMVGLALTSIVILGSAIVLRLPSNAMRFAFWIALGVLCAGFFQMGIAVVFGVIALL VAVCWFIKGGKDTLTICLHALVDGARHAVPVGIACALVGVIIGIVSLTGIASTFASYILA VGQDNLFLSLVLTMLTCMVLGMGIPSIPNYIITSSIAAPALLDLGVPLIVSHMFVFYFGI MADLTPPVALACFAAAPIAKESGLKISLWAIRIAIAGFVIPFMAVYEPALMLQSDSWLAI GFVMLKATVGIGIWGVIFTGFLLQKLYWWERVIGFLAGASLILATPLSDEIGFGLALLFI VQHSLRVRKLKRLAEQG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server